Novel Technologies News for August 2009

Novel Technologies News Archive

PerkinElmer signs exclusive licensing agreement with Max Planck Innovation for silicon photomultiplier technology PerkinElmer signs exclusive licensing agreement with Max Planck Innovation for silicon photomultiplier technology

Medical diagnosis requires doctors to make difficult decisions, beginning with the selection of the right diagnostic method.

Genetically engineered bacteria are sweet success against inflammatory bowel disease Genetically engineered bacteria are sweet success against inflammatory bowel disease

For the first time, scientists have used a genetically engineered ‘friendly’ bacterium to deliver a therapy.

New immune-suppressing treatment forces multiple sclerosis into remission in mice New immune-suppressing treatment forces multiple sclerosis into remission in mice

A new experimental treatment for multiple sclerosis completely reverses the devastating autoimmune disorder in mice and might work exactly the same way in humans, say researchers at the Jewish General Hospital Lady Davis Institute for Medical Research and McGill University in Montreal.

Marine microbes creating green waves in industry Marine microbes creating green waves in industry

New technology designed to analyze large numbers of novel marine microbes could lead to more efficient and greener ways to manufacture new drugs for conditions such as epilepsy, diabetes, and flu and other viruses, as well as improving the manufacture of other products, such as agrochemicals.

Plant-based technology instrumental in flu vaccine production Plant-based technology instrumental in flu vaccine production

Medicago, the John Innes Centre and Plant Bioscience Limited announced recently that Medicago's 14-day production of the H1 virus-like particle antigen was achieved using, among other technologies, a technology that was invented by John Innes Centre researchers and is licensed by Plant Bioscience Limited to Medicago.